245 related articles for article (PubMed ID: 23407780)
1. Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.
Mitjans M; Serretti A; Fabbri C; Gastó C; Catalán R; Fañanás L; Arias B
Psychopharmacology (Berl); 2013 Jun; 227(3):509-19. PubMed ID: 23407780
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.
Mitjans M; Gastó C; Catalán R; Fañanás L; Arias B
J Psychopharmacol; 2012 Oct; 26(10):1391-8. PubMed ID: 22826533
[TBL] [Abstract][Full Text] [Related]
3. Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.
Arias B; Serretti A; Mandelli L; Gastó C; Catalán R; Ronchi DD; Fañanás L
Pharmacogenet Genomics; 2009 Feb; 19(2):121-8. PubMed ID: 19065121
[TBL] [Abstract][Full Text] [Related]
4. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
[TBL] [Abstract][Full Text] [Related]
7. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
9. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
[TBL] [Abstract][Full Text] [Related]
10. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
[TBL] [Abstract][Full Text] [Related]
12. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
Arias B; Serretti A; Lorenzi C; Gastó C; Catalán R; Fañanás L
J Affect Disord; 2006 Feb; 90(2-3):251-6. PubMed ID: 16356553
[TBL] [Abstract][Full Text] [Related]
13. SLC6A4 variation and citalopram response.
Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.
Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM
Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588
[TBL] [Abstract][Full Text] [Related]
15. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
16. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
17. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
18. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
Matreja PS; Badyal DK; Khosla P; Deswal RS
Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
